Latest filing published 13 Aug 2021 for Neogenomics INC, €230k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +141.8%Entry US$1.10 · Close at T+365 US$2.66
- +140.0%Entry US$1.15 · Close at T+365 US$2.76
- +93.9%Entry US$1.15 · Close at T+365 US$2.23
- +26.9%Entry US$1.30 · Close at T+365 US$1.65
- +17.6%Entry US$1.42 · Close at T+365 US$1.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Douglas M. Van Oort: trading record in brief
Douglas M. Van Oort is a declared insider at 2 companies (board member); the most frequent names are Neogenomics Inc and Renovare Environmental, Inc. In total, 60 filings cover trades dated from 6 May 2011 to 1 August 2021.
In open-market terms, that means 11 purchases worth €20k on one side and 8 sales worth €22.8M on the other. The net balance comes to €22.8M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 21 share grants and 8 option exercises.
In size, the median ticket on the buying side is €1,808. After 11 purchases with a full 90-day history, the hit rate stands at 45% and the median 90-day move at -6.6%. These figures describe past trades and do not predict future prices.
On 13 August 2021 came the latest disclosure, a share grant for €230k in Neogenomics Inc. The latest purchase dates back some time: it was published 5,532 days ago, on 16 September 2011. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas M. Van Oort
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,919 shares@ US$46.10100.0% of flowCommon StockSEC:0001077183-21-000210:0
- 2,339 shares0Common StockSEC:0001077183-21-000086:0
- 2,158 shares0Common StockSEC:0001077183-21-000086:1
- 56,423 shares0Common StockSEC:0001077183-21-000086:2
- 121,248 shares@ US$7.525.0% of flowCommon StockSEC:0001077183-20-000211:0
- 121,248 shares@ US$42.1828.0% of flowCommon StockSEC:0001077183-20-000211:1
- 358,752 shares@ US$7.5214.7% of flowCommon StockSEC:0001077183-20-000211:2
- 118,752 shares@ US$41.5627.0% of flowCommon StockSEC:0001077183-20-000211:3
- 100,000 shares@ US$42.3423.0% of flowCommon StockSEC:0001077183-20-000211:5
- 20,000 shares@ US$7.520.8% of flowCommon StockSEC:0001077183-20-000211:4
- 10,000 shares0Common StockSEC:0001077183-20-000183:0
- 5,000 shares0Common StockSEC:0001077183-20-000183:1
- 5,000 shares0Common StockSEC:0001077183-20-000183:2
- 10,000 shares0Common StockSEC:0001077183-20-000183:3
- 5,953 shares0Common StockSEC:0001077183-20-000173:0
- 22,330 shares0Common StockSEC:0001077183-20-000118:0
- 2,353 shares0Common StockSEC:0001077183-20-000032:0
- 34,945 shares0Common StockSEC:0001077183-20-000032:1
- 187,500 shares@ US$24.0818.0% of flowCommon StockSEC:0001077183-19-000217:0
- 6,090 shares0Common StockSEC:0001077183-19-000208:0
- 205,635 shares0Common StockSEC:0001077183-19-000208:2
- 472,527 shares@ US$7.1513.5% of flowCommon StockSEC:0001077183-19-000208:1
- 30,000 shares0Common StockSEC:0001077183-19-000164:0
- 10,000 shares0Common StockSEC:0001077183-19-000164:1
- 10,000 shares0Common StockSEC:0001077183-19-000164:2
25 of 59 declarations
